The first genome-wide association study (GWAS) in IgA vasculitis worldwide has been conducted by the research group of IDIVAL “Genetic epidemiology and atherosclerosis in systemic inflammatory diseases”, led by Dr. Miguel Ángel González-Gay, in collaboration with other Hospitals and national and international Institutes. Immunoglobulin-A (IgA) vasculitis, also known as Henoch-Schöenlein purpura (HSP), is the most […]
Following the success achieved in the first program of Santander Biomedical Lectures, IDIVAL introduces the second program of conferences. World’s prestigious and recognized researchers for their international contributions in the advancement of fields such as Immunology, Nanomedicine, Molecular Biology or Rheumatology are taken part on this program. For a consecutive year, the Cantabria Research Forum, […]
IMI2 (Innovative Medicines Initiative) is a public-private initiative between the European Union and EFPIA (European Federation of Pharmaceutical Industries and Associations). Its purpose is to create partnerships that promote the development of drugs of the future. IMI2 has launched its 12th call, through which it will finance projects encompassed within the following lines: Topic 1:Development […]
